Lawmakers lash out at Mylan over EpiPen profit revision

Lawmakers lash out at Mylan over EpiPen profit revision-stat: Lawmakers on Monday lashed out at the drug maker Mylan after a fresh disclosure that the company’s chief executive may have misrepresented the profits it earns on sales of EpiPens.